Year: 2011
Type: review
Abstract: BACKGROUND: Chronic inflammation may participate in the pathogenesis of insulin resistance, type 2 diabetes, and cardiovascular disease and may be a common denominator that links obesity to these disease states. CONTENT: Epidemiologic studies have linked inflammatory biomarkers to incident diabetes and cardiovascular disease risk. Cellular and animal studies have provided support to the idea that inflammation mediates these disease processes, providing impetus to pharmacologically target these pathways for disease treatment and prevention. We review clinical strategies to target inflammation, with a focus on the antiinflammatory and antihyperglycemic effects of salicylates. SUMMARY: The evolving concept of diet-induced obesity driving insulin resistance, type 2 diabetes, and cardiovascular disease through immunologic processes provides new opportunities for the use of antiinflammatory strategies to correct the metabolic consequences of excess adiposity.
Source: Clinical Chemistry
Institutions: Joslin Diabetes Center, Harvard University, Tulane University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Mechanism-Based Biomarkers for Glucose-Lowering in TINSAL-T2D, Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate, EFFECTS OF IKKB and NFkB IN INSULIN RESISTANCE, IKK MEDIATED INSULIN RESISTANCE AND IN VIVO REVERSAL, General Clinical Research Center, Mediators and Modifiers of NF-kappaB in Insulin Resistance, TOLL RECEPTOR ACTIVATION OF NF-kB IN INSULIN RESISTANCE AND T2DM, General Clinical Research Center, Targeting Inflammation to Improve Endothelial Function in Type 2 Diabetes: A Subs, Metabolic Syndrome, Inflammation and Vascular Remodeling, Diabetes Research Center
OpenAlex ID: W2011373763
